GB2232892A - Occlusive body for administering a physiologically active substance - Google Patents

Occlusive body for administering a physiologically active substance

Info

Publication number: GB2232892A
Authority: GB; United Kingdom
Prior art keywords: administering; active substance; physiologically active; occlusive body; occlusive
Prior art date: 1988-02-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Inventor

John Mark Tucker

Mark Rupert Tucker

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-23

Filing date

1989-02-23

Publication date

1991-01-02

1988-02-23Priority claimed from GB888804164Aexternal-prioritypatent/GB8804164D0/en

1989-02-23Application filed by IndividualfiledCriticalIndividual

1989-02-23Priority to GB9014721ApriorityCriticalpatent/GB2232892B/en

1990-10-03Publication of GB9014721D0publicationCriticalpatent/GB9014721D0/en

1991-01-02Publication of GB2232892ApublicationCriticalpatent/GB2232892A/en

1991-07-24Application grantedgrantedCritical

1991-07-24Publication of GB2232892BpublicationCriticalpatent/GB2232892B/en

2009-02-23Anticipated expirationlegal-statusCritical

StatusExpired - Lifetimelegal-statusCriticalCurrent

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)

GB9014721A1988-02-231989-02-23Occlusive body for administering a physiologically active substanceExpired - LifetimeGB2232892B (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GB9014721AGB2232892B (en)	1988-02-23	1989-02-23	Occlusive body for administering a physiologically active substance

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB888804164AGB8804164D0 (en)	1988-02-23	1988-02-23	Bandage for administering physiologically active compound
PCT/GB1989/000185WO1989007959A1 (en)	1988-02-23	1989-02-23	Occlusive body for administering a physiologically active substance
GB9014721AGB2232892B (en)	1988-02-23	1989-02-23	Occlusive body for administering a physiologically active substance

Publications (3)

Publication Number	Publication Date
GB9014721D0 GB9014721D0 (en)	1990-10-03
GB2232892Atrue GB2232892A (en)	1991-01-02
GB2232892B GB2232892B (en)	1991-07-24

Family

ID=26293526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB9014721AExpired - LifetimeGB2232892B (en)	1988-02-23	1989-02-23	Occlusive body for administering a physiologically active substance

Country Status (1)

Country	Link
GB (1)	GB2232892B (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2314025A (en)*	1996-06-13	1997-12-17	Anthony Clive Umfrevill Fisher	Footwear deodoriser
WO1999052513A1 (en)	1998-04-14	1999-10-21	Stowic Resources Limited	Method of manufacturing transdermal patches
WO2002062314A1 (en)*	2001-02-02	2002-08-15	United Pharmaceuticals Manufacturing Co. Limited	Oral drug delivery system
WO2010141861A1 (en)	2009-06-05	2010-12-09	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
US8273361B2 (en)	2006-09-26	2012-09-25	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US8343512B2 (en)	2006-09-26	2013-01-01	Infectious Disease Research Institute	Treatment of allergic conditions using a composition containing synthetic adjuvant
WO2014172637A1 (en)	2013-04-18	2014-10-23	Immune Design Corp.	Gla monotherapy for use in cancer treatment
US9044420B2 (en)	2011-04-08	2015-06-02	Immune Design Corp.	Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
WO2015112485A1 (en)	2014-01-21	2015-07-30	Immune Design Corp.	Compositions for use in the treatment of allergic conditions
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
WO2017200957A1 (en)	2016-05-16	2017-11-23	Infectious Disease Research Institute	Pegylated liposomes and methods of use
WO2017200852A1 (en)	2016-05-16	2017-11-23	Infectious Disease Research Institute	Formulation containing tlr agonist and methods of use
WO2017210364A1 (en)	2016-06-01	2017-12-07	Infectious Disease Research Institute	Nanoalum particles containing a sizing agent
US9895435B2 (en)	2012-05-16	2018-02-20	Immune Design Corp.	Vaccines for HSV-2
EP3563834A1 (en)	2012-02-07	2019-11-06	Infectious Disease Research Institute	Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
US11739054B2 (en)	2017-06-11	2023-08-29	Molecular Express, Inc.	Methods and compositions for substance use disorder vaccine formulations and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3598122A (en)*	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
US4067961A (en)*	1975-03-19	1978-01-10	The Procter & Gamble Company	Controlled release article
EP0186019A2 (en)*	1984-12-22	1986-07-02	Schwarz Pharma Ag	Medicated dressing
EP0197504A2 (en)*	1985-04-05	1986-10-15	Merck & Co. Inc.	pH-mediated drug delivery system
GB2174605A (en)*	1985-05-03	1986-11-12	Alza Corp	Transdermal drug delivery
EP0208395A1 (en)*	1985-05-16	1987-01-14	Euroceltique S.A.	Transdermal delivery system

1989
- 1989-02-23GBGB9014721Apatent/GB2232892B/ennot_activeExpired - Lifetime

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3598122A (en)*	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
US3598122B1 (en)*	1969-04-01	1982-11-23
US4067961A (en)*	1975-03-19	1978-01-10	The Procter & Gamble Company	Controlled release article
EP0186019A2 (en)*	1984-12-22	1986-07-02	Schwarz Pharma Ag	Medicated dressing
EP0197504A2 (en)*	1985-04-05	1986-10-15	Merck & Co. Inc.	pH-mediated drug delivery system
GB2174605A (en)*	1985-05-03	1986-11-12	Alza Corp	Transdermal drug delivery
EP0208395A1 (en)*	1985-05-16	1987-01-14	Euroceltique S.A.	Transdermal delivery system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
International Journal of Pharmaceutics, vol. 48, 1988, pages247-254*

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2314025A (en)*	1996-06-13	1997-12-17	Anthony Clive Umfrevill Fisher	Footwear deodoriser
GB2314025B (en)*	1996-06-13	2000-05-03	Anthony Clive Umfrevill Fisher	Footwear deodoriser
WO1999052513A1 (en)	1998-04-14	1999-10-21	Stowic Resources Limited	Method of manufacturing transdermal patches
WO2002062314A1 (en)*	2001-02-02	2002-08-15	United Pharmaceuticals Manufacturing Co. Limited	Oral drug delivery system
AU2002228213B2 (en)*	2001-02-02	2006-10-26	United Pharmaceuticals Manufacturing Co. Limited	Oral drug delivery system
EP3795173A1 (en)	2006-09-26	2021-03-24	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US8343512B2 (en)	2006-09-26	2013-01-01	Infectious Disease Research Institute	Treatment of allergic conditions using a composition containing synthetic adjuvant
US8609114B2 (en)	2006-09-26	2013-12-17	Infectious Diesease Research Institute	Methods of using a vaccine composition containing synthetic adjuvant
US8840908B2 (en)	2006-09-26	2014-09-23	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US9950063B2 (en)	2006-09-26	2018-04-24	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US9907845B2 (en)	2006-09-26	2018-03-06	Infectious Disease Research Institute	Methods of using a vaccine composition containing synthetic adjuvant
US9987355B2 (en)	2006-09-26	2018-06-05	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
EP3403667A1 (en)	2006-09-26	2018-11-21	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US10792359B2 (en)	2006-09-26	2020-10-06	Infectious Disease Research Institute	Methods of using a vaccine composition containing synthetic adjuvant
US10765736B2 (en)	2006-09-26	2020-09-08	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US8273361B2 (en)	2006-09-26	2012-09-25	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
EP3251680A1 (en)	2008-05-22	2017-12-06	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US9480740B2 (en)	2009-06-05	2016-11-01	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
US9814772B2 (en)	2009-06-05	2017-11-14	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
US10632191B2 (en)	2009-06-05	2020-04-28	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
EP3124491A1 (en)	2009-06-05	2017-02-01	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
WO2010141861A1 (en)	2009-06-05	2010-12-09	Infectious Disease Research Institute	Synthetic glucopyranosyl lipid adjuvants
US9044420B2 (en)	2011-04-08	2015-06-02	Immune Design Corp.	Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
EP3563834A1 (en)	2012-02-07	2019-11-06	Infectious Disease Research Institute	Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
US11510875B2 (en)	2012-02-07	2022-11-29	Access To Advanced Health Institute	Adjuvant formulations comprising TLR4 agonists and methods of using the same
US9895435B2 (en)	2012-05-16	2018-02-20	Immune Design Corp.	Vaccines for HSV-2
WO2014172637A1 (en)	2013-04-18	2014-10-23	Immune Design Corp.	Gla monotherapy for use in cancer treatment
US8962593B2 (en)	2013-04-18	2015-02-24	Immune Design Corp.	GLA monotherapy for use in cancer treatment
US10342815B2 (en)	2013-04-18	2019-07-09	Immune Design Corp.	GLA monotherapy for use in cancer treatment
US8957047B2 (en)	2013-04-18	2015-02-17	Immune Design Corp.	GLA monotherapy for use in cancer treatment
US10993956B2 (en)	2013-04-18	2021-05-04	Immune Design Corp.	GLA monotherapy for use in cancer treatment
EP3711768A1 (en)	2013-04-18	2020-09-23	Immune Design Corp.	Gla monotherapy for use in cancer treatment
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
WO2015112485A1 (en)	2014-01-21	2015-07-30	Immune Design Corp.	Compositions for use in the treatment of allergic conditions
WO2017200957A1 (en)	2016-05-16	2017-11-23	Infectious Disease Research Institute	Pegylated liposomes and methods of use
US11266602B2 (en)	2016-05-16	2022-03-08	Infectious Disease Research Institute	PEGylated liposomes and methods of use
WO2017200852A1 (en)	2016-05-16	2017-11-23	Infectious Disease Research Institute	Formulation containing tlr agonist and methods of use
EP4112638A1 (en)	2016-05-16	2023-01-04	Access to Advanced Health Institute	Formulation containing tlr agonist and methods of use
WO2017210364A1 (en)	2016-06-01	2017-12-07	Infectious Disease Research Institute	Nanoalum particles containing a sizing agent
US11739054B2 (en)	2017-06-11	2023-08-29	Molecular Express, Inc.	Methods and compositions for substance use disorder vaccine formulations and uses thereof

Also Published As

Publication number	Publication date
GB9014721D0 (en)	1990-10-03
GB2232892B (en)	1991-07-24

Publication	Publication Date	Title
ZA891403B (en)	1989-11-29	Occlusive body for administering a physiologically active substance
GR1002252B (en)	1996-04-23	A novel therapeutic active compound and preparation method therefore.
GB8828477D0 (en)	1989-01-05	Medical aerosol formulations
AU2550288A (en)	1989-05-02	A medical device for introduction into a body cavity
GB2232892B (en)	1991-07-24	Occlusive body for administering a physiologically active substance
AU3926589A (en)	1990-02-22	Pharmaceutical compounds exhibiting somatostatin-like activity
GR3023006T3 (en)	1997-07-30	Medicament for augmenting fetal hemoglobin
ZA898201B (en)	1991-03-27	Gestodene-containing agent for transdermal administration
EP0294053A3 (en)	1990-06-27	Physiologically active agent for agricultural use
EP0370673A3 (en)	1990-06-27	Therapeutic agent for aids
EP0450100A4 (en)	1993-02-17	Physiologically active peptide
AU8303687A (en)	1988-06-30	Composition for administration through a body cavity
ZA899948B (en)	1990-09-26	Pharmaceutical preparation
EP0455818A4 (en)	1993-05-12	Physiologically active substance be-16627
EP0366614A3 (en)	1990-06-27	Pharmaceutically active dithioketene derivatives
GB8902424D0 (en)	1989-03-22	Medicinal formulations
AU8640491A (en)	1992-04-28	Device for administering a physiologically active substance to the gastro-intestinal tract
GB8805811D0 (en)	1988-04-13	Pharmaceutically active compounds
IE882467L (en)	1989-02-15	Pharmaceutical preparation for external use
GB8901158D0 (en)	1989-03-15	Administering drugs
GB8914384D0 (en)	1989-08-09	A capsule for a medicament
BG48198A1 (en)	1990-12-14	Active sonorifying body
SG171194G (en)	1995-04-28	Pharmaceutically active dithioketene derivatives
GB8821120D0 (en)	1988-10-05	Therapeutic substance
GB8814742D0 (en)	1988-07-27	Medicament inhalation device

Legal Events

Date	Code	Title	Description
1995-09-06	732E	Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
2004-10-27	732E	Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
2008-10-29	PCNP	Patent ceased through non-payment of renewal fee	Effective date:20080223

Movatterモバイル変換